Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 1

Conditions

Leukemia 60Myelodysplastic Syndromes 53Leukemia, Myeloid, Acute 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Leukemia, Lymphocytic, Chronic, B-Cell 42Lymphoma, Non-Hodgkin 41Hodgkin Disease 38Multiple Myeloma 35Lymphoma, Mantle-Cell 33Lymphoma 33Lymphoma, Large B-Cell, Diffuse 31Lymphoma, Follicular 30Leukemia, Myeloid, Chronic-Phase 30Myeloproliferative Disorders 27Lymphoma, B-Cell, Marginal Zone 27Burkitt Lymphoma 26Congenital Abnormalities 25Lymphoma, Large-Cell, Immunoblastic 24Anemia, Refractory, with Excess of Blasts 24Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Leukemia, Myeloid, Accelerated Phase 21Graft vs Host Disease 21Leukemia, Myelomonocytic, Chronic 20Blast Crisis 19Dendritic Cell Sarcoma, Interdigitating 17Anemia, Refractory 17Recurrence 16Waldenstrom Macroglobulinemia 15Neoplasms, Plasma Cell 15Myelodysplastic-Myeloproliferative Diseases 15

Interventions

Cyclophosphamide 14fludarabine 12fludarabine phosphate 8Melphalan 8Brentuximab Vedotin 8Whole-Body Irradiation 7Mycophenolic Acid 7Busulfan 7Rituximab 6Tacrolimus 5Lenalidomide 4Etoposide 4isatuximab 3Sirolimus 3Mesna 3Granulocyte Colony-Stimulating Factor 3Dexamethasone 3pembrolizumab 2nilotinib 2dacetuzumab 2Vincristine 2Thiotepa 2Sugars 2Stem Cell Transplantation 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Ondansetron 2N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 2Methotrexate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Hematologic Diseases × Cyclosporine × Clear all
NCT03246906 2026-05-14

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Fred Hutchinson Cancer Center

Phase 2 Terminated
150 enrolled 18 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hematologic Diseases, Hodgkin Disease, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT00636909 2017-04-06

MINI HEME

Beth Israel Deaconess Medical Center

Phase 2 Completed
25 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Blast Crisis, Hematologic Diseases, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡